Examkin

Question

Difficulty: MediumPharmacologic Interventions

An emergency response team is actively resuscitating a 34-year-old individual who was found unresponsive with continuous, generalized tonic-clonic movements. Paramedics report the seizure activity has persisted without interruption for at least 20 minutes prior to arrival. Two large-bore intravenous lines are rapidly secured. Vital signs show a blood pressure of 142/88142/88 mmHg, heart rate of 118118/min, and oxygen saturation of 96%96\% on high-flow oxygen. A point-of-care blood glucose reading is 112112 mg/dL. Arrange the following pharmacologic therapies in the correct sequential order of administration for the escalating algorithmic management of this condition.

  1. 1Administer an intravenous bolus of lorazepam
  2. 2Administer a loading dose of intravenous fosphenytoin
  3. 3Initiate a continuous intravenous infusion of midazolam
  4. 4Initiate a continuous intravenous infusion of pentobarbital

Answer

The correct sequence begins with intravenous lorazepam, followed by a loading dose of fosphenytoin, then a continuous midazolam infusion, and finally a continuous pentobarbital infusion if the condition becomes super-refractory.
The established algorithmic approach to status epilepticus prioritizes the rapid cessation of seizure activity, followed by the prevention of recurrence, and progressively more suppressive therapies if seizures persist. Intravenous lorazepam provides the most rapid onset of action. Fosphenytoin is then loaded to establish durable seizure control. If seizures continue, continuous anesthetic infusions like midazolam are initiated. Pentobarbital is reserved for super-refractory cases due to its risk of profound hemodynamic collapse.

Step-by-Step Solution

1
Identify the clinical presentation as status epilepticus.
The patient has experienced greater than 5 minutes of continuous seizure activity.
Recognizing status epilepticus immediately triggers a strict, time-sensitive escalating pharmacologic protocol to prevent irreversible neurologic injury.
2
Select the first-line emergent medication.
Intravenous lorazepam.
Benzodiazepines have the fastest onset of action and are the most effective first-line agents for terminating active seizures.
3
Determine the subsequent urgent control therapy.
Intravenous fosphenytoin.
Because benzodiazepines have a short duration of action, a long-acting non-benzodiazepine antiseizure medication must be loaded to prevent seizure recurrence.
4
Determine the approach for refractory status epilepticus.
Continuous intravenous midazolam.
If seizures continue despite first- and second-line agents, continuous anesthetic infusions are required to achieve burst suppression on EEG.
5
Select the therapy for super-refractory cases.
Continuous intravenous pentobarbital.
When standard continuous anesthetics fail, highly suppressive barbiturate coma is initiated, though it is reserved for last due to severe side effects.

Key Concept

The algorithmic pharmacologic escalation for status epilepticus prioritizes rapid seizure cessation (benzodiazepines), followed by recurrence prevention (fosphenytoin/levetiracetam), and subsequently continuous deep sedation (midazolam/propofol) if seizures persist.
Estimated Time:1m 30s
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic